Type Whole antibody ATC code none ChemSpider none | Source Humanized CAS Number 1167985-17-2 Formula C1682H2608N472O538S12 | |
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.
Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm.
References
Ozoralizumab Wikipedia(Text) CC BY-SA